Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We are upgrading Montpelier Re Holdings Ltd. ( MRH - Analyst Report ) to Outperform from Neutral on the back of solid first quarter results.
Operating earnings in the first quarter breezed past the Zacks Consensus and also reversed the year-ago loss. A substantial decline in loss and loss adjustment expenses boosted the profitability in the quarter.
In order to return more value to its shareholders, the company’s Board approved a dividend hike of 5%. Its dividend yield is presently 2.04%. The company also buys back shares to enhance shareholders value.
In the first quarter, the company spent $37 million to buyback 1.95 million shares with 1.03 million shares already repurchased for $20 million in the second quarter. Also, the company is left with $107.7 million in its share buyback authorization as of March 31, 2012.
Further, the company benefits from tax exemptions in Bermuda as no income taxes are levied there. Also, Bermuda Minister of Finance has assured exemption of Bermuda-imposed income, withholdings and capital gains and taxes until 2035 on all Bermuda-based subsidiaries.
Besides, the company scores strongly with the credit rating agencies.
On the flip side, Montpelier has substantial exposure to losses resulting from natural and man-made disasters and other catastrophic events. Many of its insurance and reinsurance policies cover unpredictable natural and other disasters such as hurricanes, windstorms, earthquakes, floods, fires,explosions and terrorism.
Nevertheless, the entire industry benefited from lower cat loss in the first quarter. However, exposure to cat activities will always remain a concern as natural disasters can affect the results adversely.
Montpelieris experiencing a weakness in its commercial property book. Its ability to sustain the level of price improvement as seen earlier in 2009 is increasingly becoming challenging owing to the stressed economic conditions.
The Zacks Consensus Estimate for second quarter 2012 and full year 2012 are 65 cents and $2.96 per share, respectively. The quantitative Zacks #2 Rank (short term Buy rating) for the company indicates slight boost on the stock over the near term.
Montpeliercompetes with Flagstone Reinsurance Holdings SA ( ) , RenaissanceRe Holdings Ltd. ( RNR - Analyst Report ) and Validus Holdings, Ltd. ( VR - Snapshot Report ) .
Read the full Analyst Report on MRH
Read the full Analyst Report on RNR
Read the full Snapshot Report on VR